The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.
 
Jean-Marc Classe
Consulting or Advisory Role - GlaxoSmithKline; GlaxoSmithKline; Myriad Genetics; Roche
Travel, Accommodations, Expenses - MSD Oncology
 
Loic Campion
No Relationships to Disclose
 
Fabrice Lecuru
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akeso Biopharma; AstraZeneca; Bristol Myers Squibb; Deciphera; Eisai; Elevar Therapeutics; Exelixis; Genmab; GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; MSD; Novartis; Novocure; Oncoinvent; OncXerna Therapeutics; Regeneron; Roche; Sanofi; Seagen; Sotio; Verastem; Zentalis
Research Funding - Amgen (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genmab; Karyopharm Therapeutics; Novocure
 
Clémentine Jankowski
Consulting or Advisory Role - Lilly; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Romuald Wernert
No Relationships to Disclose
 
Christophe Pomel
No Relationships to Disclose
 
Gilles Houvenaeghel
No Relationships to Disclose
 
Pierre-Francois Dupre
No Relationships to Disclose
 
Patrice Mathevet
No Relationships to Disclose
 
Richard Villet
No Relationships to Disclose
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; sanofi/3A; Seagen; Viatris
Travel, Accommodations, Expenses - AstraZeneca; BMS; Chugai Pharma; Eisai; Eisai; Eisai; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology
 
Dominique Berton
No Relationships to Disclose
 
Emilie Debeaupuis
No Relationships to Disclose
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Cecile Loaec
No Relationships to Disclose